CGK733 2,2-二苯基-N-(2,2,2-三氯-1-(3-(4-氟-3-硝基苯基)硫脲基)乙基)乙酰胺
CAS 905973-89-9 MFCD09038682
化学结构图
SMILES: O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1
化学属性
| Mol. Formula | C23H18Cl3FN4O3S |
|---|---|
| Mol. Weight | 555.84 |
| Appearance | Solid powder |
| Solubility | Soluble in DMSO, not in water |
别名和识别编码
| Chemical Name | CGK733 |
|---|---|
| Synonym | 2,2-Diphenyl-n-(2,2,2-trichloro-1-[3-(4-fluoro-3-nitrophenyl)thioureido]ethyl)acetamide CGK733 CGK733; CGK-733; CGK 733. |
| MDL Number | MFCD09038682 |
| PubChem Substance ID | 24724454 |
| Chemical Name Translation | 2,2-二苯基-N-(2,2,2-三氯-1-(3-(4-氟-3-硝基苯基)硫脲基)乙基)乙酰胺 |
| Formula | C23H18Cl3FN4O3S |
| IUPAC Name | 2,2-diphenyl-N-(2,2,2-trichloro-1-(3-(4-fluoro-3-nitrophenyl)thioureido)ethyl)acetamide |
| InChIKey | HLCDNLNLQNYZTK-UHFFFAOYSA-N |
| InChI | InChI=1S/C23H18Cl3FN4O3S/c24-23(25,26)21(30-22(35)28-16-11-12-17(27)18(13-16)31(33)34)29-20(32)19(14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-13,19,21H,(H,29,32)(H2,28,30,35) |
| Canonical SMILES | O=C(NC(NC(NC1=CC=C(F)C([N+]([O-])=O)=C1)=S)C(Cl)(Cl)Cl)C(C2=CC=CC=C2)C3=CC=CC=C3 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- ATM, Cell Biology, Cell Signaling and Neuroscience, Kinase/Phosphatase Biology, Protein Kinase Inhibitors, Serine/Threonine Kinase Biology, Serine/Threonine Kinase Inhibitors
- {SNA} ATM, Bioactive Small Molecule Alphabetical Index, C-CH, Kinase/Phosphatase Biology, Protein Kinase Inhibitors, Serine/Threonine Kinase Biology, Serine/Threonine Kinase Inhibitors, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
- {SNA} ATM, Cell Biology, Cell Signaling and Neuroscience, Kinase/Phosphatase Biology, Protein Kinase Inhibitors, Serine/Threonine Kinase Biology, Serine/Threonine Kinase Inhibitors
产品应用
- CGK733 is an ATM inhibitor and ATR inhibitor, which significantly enhanced taxol-induced cytotoxicity in HBV-positive HepG2.2.15 cells. The mechanism lies in CGK733 triggers the formation of multinucleated cells thus promotes the premature mitotic exit of taxol-induced mitotic-damaged cells through multinucleation and mitotic catastrophe in HBV-positive HepG2.2.15 cells. These results suggest that CGK733 could potentially reverse the taxol resistance in HBV-positive HCC cells and may suggest a novel strategy to treat HBV-infected HCC patients.
相关文献及参考
- RETRACTED. Won, J., et al., Small molecule-based reversible reprogramming of cellular lifespan Nature Chem. Biol. , 369-774, (2006)
- Wang, H., et al., CGK733 enhances multinucleated cell formation and cytotoxicity induced by taxol in Chk1-deficient HBV-positive hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 422 , 103-108, (2012)
